In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Beiersdorf eyes U.S. opportunities

This article was originally published in The Rose Sheet

Executive Summary

Company it is interested in making acquisitions in the U.S. in order to strengthen its presence stateside, CEO Rolf Kunisch states during its annual meeting in Hamburg, Germany June 11. U.S. is firm's second largest market after Germany, with sales of more than $300 mil., exec reports. "Nevertheless, the U.S. is so big that increasing our sales even further would be helpful," he notes. Company expects consolidated 2003 sales to be up 7% at constant exchange rates, Kunisch projects...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS011296

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel